First diagnostic test for Alzheimer’s and Parkinson’s disease
April 8, 2008 | Source: KurzweilAI
Power3 Medical Products is launching what it claims is the first blood test for neurodegenerative diseases such as Parkinson’s, Lou Gehrig’s and Alzheimer’s.
The test measures a suite of 59 protein biomarkers associated with the presence or absence of these diseases. Currently, there are no diagnostic tests, only clinical diagnosis of symptoms.
Other researchers urge caution, since larger studies haven’t yet confirmed the test, and diseases like Alzheimer’s may be too complicated to diagnose with this method. Two clinical validation studies are underway in the US and Greece.